Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)

Author(s):  Riepl Mike

Issue:  May/Jun 2019 - Volume 23, Number 3
View All Articles in Issue

Page(s):  192-199

Download in electronic PDF format for $65

Abstract:  Polycystic ovary syndrome (Stein- Leventhal syndrome) is a common endocrinopathologic condition in reproductive- age women in the U.S. Patients with that disease are not faced with treatment choices for a single medical entity; they must manage a constellation of comorbid conditions that compromise their overall health and diminish their quality of life. The combinations of those disorders are unique to each patient. As a result, the safest and most effective therapeutic approach often requires precision pharmacy: the use of compounded therapies that, unlike commercially manufactured medications, can be precisely adjusted to meet individual needs and modified as therapeutic requirements change. In this article, the manifestations of polycystic ovary syndrome are reviewed, several common concomitant conditions are discussed, therapeutic interventions are suggested, and compounded formulations are provided.

Related Keywords: Mike Riepl, RPh, polycystic ovary syndrome, chronic anovulation, hyperandrogenism, polycystic ovaries, obesity, menstrual dysfunction, insulin resistance, metformin, infertility, hypothalamic-pituitary-adrenal axis, HPA axis, emotional stress, sex hormones, formulations, calcium supplementation, magnesium supplementation, vitamin D3 supplementation, zinc supplementation, hyperinsulinemia, cortisol, dietary recommendations


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
May/Jun 2019
Pg. 192-199

Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce
, Gogola Margaret
Jul/Aug 2015
Pg. 289-293

Adrenal Fatigue
Allen Loyd V Jr
Jan/Feb 2013
Pg. 39-44

The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
May/Jun 2010
Pg. 193-199

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
Nov/Dec 2021
Pg. 468-472

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina
, Garcia Lea
Jan/Feb 2001
Pg. 52-54

Infertility Care and the Role of the Compounding Pharmacist
Filicpzuk Janina
Mar/Apr 2001
Pg. 136-139

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina
, Garcia Lea
Nov/Dec 2000
Pg. 421-422

The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
Nov/Dec 2001
Pg. 462-464

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions